Ultrasound-guided percutaneous liver biopsy - A review of what operators need to know
Executive Summary
Ultrasound-guided percutaneous liver biopsy (UG-PLB) is the established gold standard for the histopathological examination of liver tissue, boasting a diagnostic sensitivity of 93% and specificity of 89% across most disease use cases. While the procedure has historical roots dating back to the late 19th century, modern technological advancements—specifically real-time ultrasound (US) guidance—have transformed it into a routine, safe, and highly successful diagnostic tool. Compared to the "blind" approach, US guidance significantly reduces complication rates and increases diagnostic yield by providing instantaneous visualization of the needle tip, thereby avoiding vascular and biliary structures.
Key takeaways include:
Clinical Utility: Primary indications include monitoring chronic viral hepatitis (B and C), diagnosing autoimmune liver pathologies, and investigating fever of unknown origin or unexplained liver function test elevations.
Safety Profile: The procedure is exceptionally safe, with a major complication rate between 0.3% and 0.5%. Bleeding is the most frequent serious adverse event, though it rarely requires surgical intervention.
Technological Preference: The use of 16- or 18-gauge spring-loaded "true cut" core biopsy needles is favored for their speed, which minimizes the impact of respiratory motion during tissue acquisition.
Operational Shift: Historically an inpatient procedure, UG-PLB is now predominantly performed on an outpatient or "same day" basis, provided patients lack specific high-risk comorbidities.
1. Clinical Indications and Contraindications
The necessity of UG-PLB is driven by the need to monitor disease progression and response to treatment in various hepatic pathologies.
1.1 Common Indications
Chronic Hepatitis: Diagnosis and monitoring of chronic hepatitis B and C.
Systemic and Storage Diseases: Investigation of hepatic steatosis, Wilson disease, hepatic storage diseases, and amyloidosis.
Autoimmune Pathologies: Primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune hepatitis.
Diagnostic Challenges: Fever of unknown origin and persistently elevated liver function tests without clear etiology.
1.2 Contraindications
Operators must categorize patients based on risk factors to determine procedural safety.
2. Equipment and Procedural Approaches
2.1 Needle Selection
The choice of needle typically depends on the clinical context and operator preference:
Cutting Needles: Retrieve a sliced segment of tissue. These are generally preferred for cases of cirrhosis.
Aspiration Needles: Rely on suction to retrieve samples. Studies indicate they may be more frequently associated with visceral perforation and sepsis.
Spring-loaded "Guns": These trigger devices are widely favored because they are quick, reducing the window for respiratory motion to interfere with sample acquisition.
2.2 Anatomical Routes
Transthoracic (Preferred): The needle is introduced through the intercostal area, typically between the 7th and 8th ribs at the midaxillary line.
Subcostal: The needle is introduced at the subcostal margin. This is less common as it requires the liver to extend past the costal margin.
3. Patient Preparation and Pre-Operative Requirements
The transition to outpatient UG-PLB has been supported by high patient satisfaction (91%) and low admission rates (2–3%).
3.1 Pre-Operative Investigations and Thresholds
Lab Work: Complete blood count (CBC), full coagulation profile (PT, INR, APTT), and bleeding time.
Coagulation Thresholds: A minimum platelet count of 50,000 and an INR of <1.6 are standard requirements. Coagulopathy may be corrected using Vitamin K, fresh frozen plasma, or platelet transfusions.
Medication Cessation:
Antiplatelets: Discontinue at least 7 days prior.
Warfarin: Discontinue 5 days prior.
Heparin: Discontinue 6 hours prior.
4. Technical Execution of the Procedure
The technical overview from an interventional radiology perspective emphasizes a sterile, guided approach using a spring-loaded cutting biopsy system.
Preparation: The patient is usually placed in a supine position (though oblique or prone may be used for specific targets). The right upper quadrant is sterilized.
Ultrasound Setup: A 5- to 7-MHz curved US probe is used with a sterile cover. Preliminary scans plan the site and needle direction.
Anesthesia: Local anesthesia is administered under US guidance down to the liver capsule, typically using a 23-gauge needle.
Needle Advancement: A 16- or 18-gauge needle is advanced toward the xiphoid process. The operator must visualize the needle tip at all times to avoid blood vessels and biliary ducts.
Sampling: The needle is fired once the tip is situated within at least 2 to 3 cm of liver parenchyma. A minimum of two full-core biopsies (20 mm longitudinal, 1 mm vertical) should be obtained.
Post-Procedural Care: Strict bed rest is required for at least 4 hours. Vital signs are monitored every 30 minutes for the first 2 hours, then hourly for the next 2 hours.
5. Complications and Risk Management
While UG-PLB is highly safe, operators must be prepared for potential adverse events, most of which manifest shortly after the procedure.
5.1 Major Complications (0.3% – 0.5%)
Bleeding: The most frequent serious adverse effect, manifesting as hemoperitoneum, subcapsular hematoma, or hemobilia. While most cases are mild, some may require transfusion or surgical intervention.
Risk Factors for Bleeding: Advanced age, malignancy, increased number of biopsy passes, and pre-existing coagulation disorders.
Mitigation: For high-risk patients, "plugged biopsies" using a gelfoam slurry as a temporary embolic agent can significantly reduce bleeding risks.
Other Major Risks: Severe intractable pain, pneumothorax, and accidental gallbladder puncture.
5.2 Minor Complications (3% – 5%)
Pain: The most common complication overall, often referred to the left shoulder. Accurate placement of anesthesia in the liver capsule by experienced operators reduces this incidence.
Vasovagal Reaction: Occurs in 1% to 3% of cases. Premedication with midazolam has been found to reduce these reactions.
5.3 Timing of Complications
Observation periods are critical as the vast majority of complications occur within 24 hours:
First 2 hours: 60% of complications.
First 10 hours: 82% of complications.
First 24 hours: 96% of complications.
6. Conclusion
The integration of real-time ultrasound guidance has established UG-PLB as a reliable and indispensable procedure in hepatology. By adhering to strict pre-operative screening, utilizing advanced spring-loaded equipment, and ensuring the continuous visualization of the biopsy needle, interventional radiologists can maximize diagnostic success while maintaining a minimal complication profile.
